Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • wisense
    Member
    • Sep 2011
    • 30

    #1

    Some issues about DE genes detection by Cuffdiff

    Hi,guys
    I have some questions in the DE genes detection by using Cuffdiff.
    I have 3 samples of paired-end RNA-seq data(Ct,Is,RP, Ct is an control sample,while Is and Rp are two treated samples), when I use Cuffdiff to find the DE genes among these 3 samples by just using all the tophat results of the 3 samples in an Cuffdiff run, the DE genes results are a bit different from that of using two samples in an Cuffdiff run. The command lines are as follows:

    Use all the 3 samples:
    Code:
    cuffdiff -o diffout_all -L Ct,Is,Rp -p 12 -b mm9.fa mm9.gtf Ct_tophat.bam Is_tophat.bam Rp_tophat.bam > cuffdiff_all.log
    Use 2 samples in one Cuffdiff run and run Cuffdiff 3 times:
    Code:
    cuffdiff -o diffout_CtvsIs -L Ct,Is -p 12 -b mm9.fa mm9.gtf Ct_tophat.bam Is_tophat.bam > cuffdiff_CtvsIs.log 
    cuffdiff -o diffout_CtvsRp -L Ct,Rp -p 12 -b mm9.fa mm9.gtf Ct_tophat.bam Rp_tophat.bam > cuffdiff_CtvsRp.log
    cuffdiff -o diffout_IsvsRp -L Is,Rp -p 12 -b mm9.fa mm9.gtf Is_tophat.bam Rp_tophat.bam > cuffdiff_IsvsRp.log
    Can anyone tell me how does this difference happen? Which way is correct to do DE genes detection when you have this type of data?

    Thanks very much~
    wisense

Latest Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    07-31-2026, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 08-03-2026, 10:13 AM
0 responses
15 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-31-2026, 02:55 AM
0 responses
32 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-24-2026, 12:17 PM
0 responses
23 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-23-2026, 11:41 AM
0 responses
21 views
0 reactions
Last Post SEQadmin2  
Working...